TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.
Brand(s)
Last updated
Summary
Product
TEVA-Codeine Tablets
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns
Affected products
Brand |
Product |
Market Authorization |
Dosage Form |
`Strength |
Lot |
|---|---|---|---|---|---|
TEVA-Codeine Tablets |
TEVA-Codeine Tablets |
DIN 00593451 |
Tablet |
Codeine Phosphate 30mg |
688579, 689203, 688771, 689154, 690234, 691161, 691891 |
Issue
This recall is due to an out of specification on friability test (broken tablet) during stability testing for affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Pharmacy
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Teva Canada Limited.
30 Novopharm Court
Toronto, ON
M1B 2K9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76728
Get notified
Receive notifications for new and updated recalls and alerts by category.